探究睡眠特征与女性乳腺癌风险之间的因果关联:孟德尔随机化研究
该研究采用孟德尔随机化方法,结合英国生物银行前瞻性队列(156 848名女性,其中7784例乳腺癌)与乳腺癌协会联盟(BCAC)病例对照全基因组关联研究(122 977例病例、105 974例对照),评估睡眠特征对乳腺癌风险的因果效应。结果显示,清晨偏好具有保护效应(BCAC两样本MR:每类别增加OR 0.88,95%CI 0.82–0.93),睡眠时间延长可能增加风险(每增加1小时OR 1.19,95%CI 1.02–1.39),而失眠症状的证据不一致。
要点
- 在英国生物银行多变量回归中,清晨偏好与乳腺癌风险呈负相关(每类别增加HR 0.95,95%CI 0.93–0.98)。
- BCAC两样本MR支持清晨偏好的保护效应(每类别增加OR 0.88,95%CI 0.82–0.93)。
- BCAC两样本MR提示睡眠时间每增加1小时与乳腺癌风险升高相关(OR 1.19,95%CI 1.02–1.39)。
核心结论
- 研究显示一致的证据支持清晨偏好对乳腺癌风险具有保护效应,并提示睡眠时间延长可能产生不良效应。
研究设计与样本
- 孟德尔随机化研究,设置包括英国生物银行前瞻性队列和乳腺癌协会联盟(BCAC)病例对照全基因组关联研究。
- 多变量回归和单样本孟德尔随机化分析纳入英国生物银行156 848名女性,其中7784例诊断为乳腺癌。
- 两样本孟德尔随机化分析纳入BCAC的122 977例乳腺癌病例和105 974例对照。
主要发现
- 英国生物银行多变量回归分析中,清晨偏好与乳腺癌风险呈负相关(每类别增加HR 0.95,95%CI 0.93–0.98),睡眠时间和失眠症状与乳腺癌关联的证据很少。
- 英国生物银行单样本孟德尔随机化分析(使用341个与 chronotype 相关的SNP、91个与睡眠时间相关的SNP、57个与失眠症状相关的SNP)为清晨偏好的保护效应提供了一些支持证据(每类别增加0.85,0.70,1.03),但睡眠时间和失眠症状的估计不精确。
- BCAC两样本孟德尔随机化支持清晨偏好的保护效应(每类别增加逆方差加权OR 0.88,95%CI 0.82–0.93)和睡眠时间增加的不良效应(每增加1小时OR 1.19,95%CI 1.02–1.39),两者在雌激素受体阳性和雌激素受体阴性乳腺癌中均存在;失眠症状的证据不一致。
- 结果在考虑水平多效性的敏感性分析中基本稳健。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 单样本孟德尔随机化分析中睡眠时间和失眠症状的估计不精确。
- 失眠症状的证据不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether sleep traits have a causal effect on risk of breast cancer. DESIGN: Mendelian randomisation study. SETTING: UK Biobank prospective cohort study and Breast Cancer Association Consortium (BCAC) case-control genome-wide association study. PARTICIPANTS: 156 848 women in the multivariable regression and one sample mendelian randomisation (MR) analysis in UK Biobank (7784 with a breast cancer diagnosis) and 122 977 breast cancer cases and 105 974 controls from BCAC in the two sample MR analysis. EXPOSURES: Self reported chronotype (morning or evening preference), insomnia symptoms, and sleep duration in multivariable regression, and genetic variants robustly associated with these sleep traits. MAIN OUTCOME MEASURE: Breast cancer diagnosis. RESULTS: In multivariable regression analysis using UK Biobank data on breast cancer incidence, morning preference was inversely associated with breast cancer (hazard ratio 0.95, 95% confidence interval 0.93 to 0.98 per category increase), whereas there was little evidence for an association between sleep duration and insomnia symptoms. Using 341 single nucleotide polymorphisms (SNPs) associated with chronotype, 91 SNPs associated with sleep duration, and 57 SNPs associated with insomnia symptoms, one sample MR analysis in UK Biobank provided some supportive evidence for a protective effect of morning preference on breast cancer risk (0.85, 0.70, 1.03 per category increase) but imprecise estimates for sleep duration and insomnia symptoms. Two sample MR using data from BCAC supported findings for a protective effect of morning preference (inverse variance weighted odds ratio 0.88, 95% confidence interval 0.82 to 0.93 per category increase) and adverse effect of increased sleep duration (1.19, 1.02 to 1.39 per hour increase) on breast cancer risk (both oestrogen receptor positive and oestrogen receptor negative), whereas evidence for insomnia symptoms was inconsistent. Results were largely robust to sensitivity analyses accounting for horizontal pleiotropy. CONCLUSIONS: Findings showed consistent evidence for a protective effect of morning preference and suggestive evidence for an adverse effect of increased sleep duration on breast cancer risk.
引用
- Richmond RC, Anderson EL, Dashti HS, et al. Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study. BMJ. 2019. PMID: 31243001. doi:10.1136/bmj.l2327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。